These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37427705)

  • 21. Plasma-derived Factor X therapy for treatment of intracranial bleeding in a patient with Factor X deficiency: a case report.
    Grottke O; Moser O; Farrag A; Elbracht M; Orlikowsky T; Trepels-Kottek S
    Transfusion; 2019 Jul; 59(7):2228-2233. PubMed ID: 30964547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spontaneous major bleeding in acquired factor X deficiency secondary to AL-amyloidosis.
    Enjeti AK; Walsh M; Seldon M
    Haemophilia; 2005 Sep; 11(5):535-8. PubMed ID: 16128899
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acquired factor X deficiency in light chain amyloidosis: a report of 2 Korean cases.
    Ma Y; Kwon EH; Lee JE; Kim K; Kim HJ; Kim SH
    Korean J Lab Med; 2011 Jul; 31(3):154-6. PubMed ID: 21779187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Acquired coagulation factor X deficiency: three cases report and literature review].
    Liu W; Xuan M; Xue F; Yang R
    Zhonghua Xue Ye Xue Za Zhi; 2014 Jul; 35(7):633-6. PubMed ID: 25052608
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Acquired factor X deficiency developed four years after autologous transplantation in a patient with multiple myeloma associated with systemic AL amyloidosis].
    Takemura T; Fukatsu Y; Nagata Y; Asahina A; Yokota D; Hirano I; Yagyu T; Ono T; Katsumi A; Ohnishi K
    Rinsho Ketsueki; 2014 May; 55(5):558-62. PubMed ID: 24881922
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence of both von Willebrand factor deposition and factor V deposition onto AL amyloid as the cause of a severe bleeding diathesis.
    Harrison JS; Frazier SR; McConnell DD; Yasar SJ; Melnyk N; Salaru G
    Blood Coagul Fibrinolysis; 2017 Jun; 28(4):342-347. PubMed ID: 27676646
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic analysis of a compound heterozygous patient with congenital factor X deficiency and regular replacement therapy with a prothrombin complex concentrate.
    Togashi T; Nagaya S; Nagasawa M; Meguro-Horike M; Nogami K; Imai Y; Kuzasa K; Sekiya A; Horike SI; Asakura H; Morishita E
    Int J Hematol; 2020 Jan; 111(1):51-56. PubMed ID: 31667683
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Successful perioperative use of prothrombin complex concentrate in the treatment of acquired factor X deficiency in the setting of systemic light-chain (AL) amyloidosis.
    Litvak A; Kumar A; Wong RJ; Smith L; Hassou H; Soff G
    Am J Hematol; 2014 Dec; 89(12):1153-4. PubMed ID: 25060940
    [No Abstract]   [Full Text] [Related]  

  • 29. Molecular basis of the clotting defect in a bleeding patient missing the Asp-185 codon in the factor X gene.
    Lu Q; Yang L; Manithody C; Wang X; Rezaie AR
    Thromb Res; 2014 Nov; 134(5):1103-9. PubMed ID: 25179519
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of non-neutralizing anti-factor X autoantibodies in three Japanese cases of autoimmune acquired factor X deficiency.
    Souri M; Osaki T; Shimura Y; Ichikawa S; Mori M; Ogawa Y; Ichinose A
    Haemophilia; 2023 Mar; 29(2):555-563. PubMed ID: 36478471
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fatal bleeding due to acquired factor IX and X deficiency: a rare complication of primary amyloidosis; case report and review of the literature.
    Ericson S; Shah N; Liberman J; Aboulafia DM
    Clin Lymphoma Myeloma Leuk; 2014 Jun; 14(3):e81-6. PubMed ID: 24290671
    [No Abstract]   [Full Text] [Related]  

  • 32. Factor X deficiency.
    Menegatti M; Peyvandi F
    Semin Thromb Hemost; 2009 Jun; 35(4):407-15. PubMed ID: 19598069
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spontaneous spinal epidural hematoma in a patient with acquired Factor X deficiency secondary to systemic amyloid light-chain amyloidosis.
    Arishima H; Tada A; Isozaki M; Kitai R; Kodera T; Kikuta K; Tai K; Iwasaki H
    J Spinal Cord Med; 2015 Sep; 38(5):641-4. PubMed ID: 24974738
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Decreased Quick percentage, acquired factor X deficiency, hemarthrosis and ecchymosis: amyloidosis].
    Bohler A; Lämmle B
    Ther Umsch; 1999 Sep; 56(9):523-5. PubMed ID: 10517125
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnosis and treatment of inherited factor X deficiency.
    Brown DL; Kouides PA
    Haemophilia; 2008 Nov; 14(6):1176-82. PubMed ID: 19141158
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prophylactic treatment of severe factor X deficiency with prothrombin complex concentrate.
    Kouides PA; Kulzer L
    Haemophilia; 2001 Mar; 7(2):220-3. PubMed ID: 11260283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An acquired, calcium-dependent, factor X inhibitor.
    Broze GJ
    Blood Cells Mol Dis; 2014; 52(2-3):116-20. PubMed ID: 24074948
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunoglobulin Light Chain Amyloidosis with Severe Liver Dysfunction Accompanied by Factor X Deficiency.
    Guo YM; Takahashi N; Miyabe K; Yoshida M; Abe F; Yamashita T; Nara M; Yoshioka T; Ohashi K; Goto A; Takahashi N
    Intern Med; 2019 Oct; 58(20):3039-3043. PubMed ID: 31243220
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Importance of pharmacokinetic studies in the management of acquired factor X deficiency.
    Lim MY; McCarthy T; Chen SL; Rollins-Raval MA; Ma AD
    Eur J Haematol; 2016 Jan; 96(1):60-4. PubMed ID: 25782416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Poor recovery and short survival of infused factor X in a case of acquired factor X deficiency and amyloidosis.
    Duncan EM; Cole J; Clarkson AR; Lloyd JV
    Thromb Haemost; 1999 Oct; 82(4):1375-6. PubMed ID: 10544941
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.